25 patents
Page 2 of 2
Utility
Genetically Engineered Hematopoietic Stem Cells and Uses Thereof
29 Jul 21
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically Engineered Hematopoietic Stem Cells and Uses Thereof
22 Jul 21
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 5 Apr 21
Utility
Genetically engineered hematopoietic stem cells and uses thereof
23 Feb 21
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 3 Dec 19
Utility
CorrectedGenetically Engineered Hematopoietic Stem Cells and Uses Thereof
28 Oct 20
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 27 Aug 19
Utility
Genetically Engineered Hematopoietic Stem Cells and Uses Thereof
7 Oct 20
Genetically engineered hematopoietic cells such as hematopoietic stem cells having one or more genetically edited genes of lineage-specific cell-surface proteins and therapeutic uses thereof, either alone or in combination with immune therapy that targets the lineage-specific cell-surface proteins.
Joseph Bolen, Aleksandar Filip Radovic-Moreno, John Lydeard
Filed: 9 Mar 20